APA (7th ed.) Citation

Loke, P., Hsiao, K., Lozinsky, A. C., Ashley, S. E., Lloyd, M., Pitkin, S., . . . Tang, M. L. (2022). Probiotic peanut oral immunotherapy is associated with long‐term persistence of 8‐week sustained unresponsiveness and long‐lasting quality‐of‐life improvement. Clinical & Experimental Allergy, 52(6), 806. https://doi.org/10.1111/cea.14137

Chicago Style (17th ed.) Citation

Loke, Paxton, et al. "Probiotic Peanut Oral Immunotherapy Is Associated with Long‐term Persistence of 8‐week Sustained Unresponsiveness and Long‐lasting Quality‐of‐life Improvement." Clinical & Experimental Allergy 52, no. 6 (2022): 806. https://doi.org/10.1111/cea.14137.

MLA (9th ed.) Citation

Loke, Paxton, et al. "Probiotic Peanut Oral Immunotherapy Is Associated with Long‐term Persistence of 8‐week Sustained Unresponsiveness and Long‐lasting Quality‐of‐life Improvement." Clinical & Experimental Allergy, vol. 52, no. 6, 2022, p. 806, https://doi.org/10.1111/cea.14137.